Sp1 recognition sites in the proximal promoter of the human vascular endothelial growth factor gene are essential for platelet-derived growth factor-induced gene expression
- PMID: 9264407
- DOI: 10.1038/sj.onc.1201219
Sp1 recognition sites in the proximal promoter of the human vascular endothelial growth factor gene are essential for platelet-derived growth factor-induced gene expression
Abstract
Stimulation of NIH3T3 cells with platelet-derived growth factor (PDGF)-BB enhances expression of vascular endothelial growth factor (VEGF), an endothelial cell-specific mitogen and a key mediator of tumor angiogenesis. Here, we identified cis-acting VEGF promoter elements and trans-acting factors which are involved in PDGF-stimulated VEGF expression. By 5'-deletion and transient transfection analysis, a G + C-rich region at -85 to -50 of the human VEGF promoter was shown to be necessary and sufficient for both PDGF inducible and basal expression. The region contains three potential recognition sites for Sp1 transcription factors, which overlap with two Egr-1 sites. Mutations that abolish the ability of Sp1 to interact with the VEGF promoter element also abrogate expression induced by PDGF. Mutations of the potential Egr-1 binding sites did not affect PDGF responsiveness. Gel shift and antibody supershift analyses showed that Sp1 and Sp3 interact constitutively with the VEGF promoter element. Our data strongly suggest that enhanced VEGF gene expression in PDGF-induced NIH3T3 cells is mediated by Sp1 and/or Sp3 transcription factors bound to the -85 to -50 promoter region of the VEGF gene.
Similar articles
-
Constitutive Sp1 activity is essential for differential constitutive expression of vascular endothelial growth factor in human pancreatic adenocarcinoma.Cancer Res. 2001 May 15;61(10):4143-54. Cancer Res. 2001. PMID: 11358838
-
Regulation of KLF5 involves the Sp1 transcription factor in human epithelial cells.Gene. 2004 Apr 14;330:133-42. doi: 10.1016/j.gene.2004.01.014. Gene. 2004. PMID: 15087132
-
Induction of VEGF gene expression by retinoic acid through Sp1-binding sites in retinoblastoma Y79 cells.Invest Ophthalmol Vis Sci. 2002 May;43(5):1367-74. Invest Ophthalmol Vis Sci. 2002. PMID: 11980848
-
Transcriptional control of the platelet-derived growth factor subunit genes.Biofactors. 1993 May;4(2):71-81. Biofactors. 1993. PMID: 8347277 Review.
-
Regulation of the tissue factor gene.Thromb Haemost. 1997 Jul;78(1):747-54. Thromb Haemost. 1997. PMID: 9198250 Review.
Cited by
-
Keratinocytic vascular endothelial growth factor as a novel biomarker for pathological skin condition.Biomol Ther (Seoul). 2015 Jan;23(1):12-8. doi: 10.4062/biomolther.2014.102. Epub 2015 Jan 1. Biomol Ther (Seoul). 2015. PMID: 25593638 Free PMC article. Review.
-
Solution structure of the major G-quadruplex formed in the human VEGF promoter in K+: insights into loop interactions of the parallel G-quadruplexes.Nucleic Acids Res. 2013 Dec;41(22):10584-92. doi: 10.1093/nar/gkt784. Epub 2013 Sep 4. Nucleic Acids Res. 2013. PMID: 24005038 Free PMC article.
-
Inhibition of pituitary tumor-transforming gene-1 in thyroid cancer cells by drugs that decrease specificity proteins.Mol Carcinog. 2011 Sep;50(9):655-67. doi: 10.1002/mc.20738. Epub 2011 Jan 25. Mol Carcinog. 2011. PMID: 21268135 Free PMC article.
-
Regulation of VEGF mRNA expression and protein secretion by TGF-beta2 in human retinal pigment epithelial cells.Exp Eye Res. 2007 May;84(5):812-22. doi: 10.1016/j.exer.2006.12.016. Epub 2007 Jan 9. Exp Eye Res. 2007. PMID: 17331500 Free PMC article.
-
Inhibitory mechanism of vascular endothelial growth factor (VEGF) by bucillamine.Br J Pharmacol. 2002 Nov;137(6):901-9. doi: 10.1038/sj.bjp.0704929. Br J Pharmacol. 2002. PMID: 12411422 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources